State of Wisconsin Investment Board’s Cartesian Therapeutics RNAC Stock Holding History

State of Wisconsin Investment Board’s Portfolio RNAC Stock Details RNAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-370	Closed	-$12.4K	–	2582
2023 Q2	$12.4K	Buy	+370	New	+$13.2K	﹤0.01%	2303
2022 Q1	–	Sell	-2,933	Closed	-$287K	–	2420
2021 Q4	$287K	Sell	2,933 -207	-7%	-$22.3K	﹤0.01%	1995
2021 Q3	$392K	Hold	3,140	–	–	﹤0.01%	1753
2021 Q2	$394K	Hold	3,140	–	–	﹤0.01%	1747
2021 Q1	$426K	Hold	3,140	–	–	﹤0.01%	1639
2020 Q4	$285K	Buy	+3,140	New	+$272K	﹤0.01%	1877
2019 Q2	–	Sell	-807	Closed	-$57K	–	1591
2019 Q1	$57K	Buy	807 +187	+30%	+$11.9K	﹤0.01%	1530
2018 Q4	$49K	Buy	+620	New	+$141K	﹤0.01%	1523

Other funds holding RNAC

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State of Wisconsin Investment Board's RNAC Position: Q3 2023 in Review

State of Wisconsin Investment Board sold out of Cartesian Therapeutics (RNAC) in Q3 2023, closing a stake of 370 shares — an estimated $12.4K sold.

State of Wisconsin Investment Board first reported a position in RNAC in Q4 2018 and held it in 8 quarters. The position peaked at $426K in Q1 2021. 87 funds tracked by Wall St. Rank hold RNAC as of Q3 2023.

State of Wisconsin Investment Board reported no remaining Cartesian Therapeutics position as of Q3 2023 after selling out during the quarter.
State of Wisconsin Investment Board sold 370 Cartesian Therapeutics shares in Q3 2023, an estimated $12.4K.
State of Wisconsin Investment Board first reported a position in Cartesian Therapeutics in Q4 2018 and held it in 8 quarters.
State of Wisconsin Investment Board's Cartesian Therapeutics position peaked at $426K in Q1 2021.
87 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2023, filed 14 Nov 2023.